Andoy, Richard D.
HRN: 03-51-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2024
06/03/2024
IV
500mg
Every 8 Hours
T/C Tonsillar Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes